231 related articles for article (PubMed ID: 26748105)
1. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
Ford LT; Berg JD
Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
[TBL] [Abstract][Full Text] [Related]
2. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.
Sobolevsky T; Prasolov I; Rodchenkov G
Drug Test Anal; 2015 Feb; 7(2):131-42. PubMed ID: 25428705
[TBL] [Abstract][Full Text] [Related]
3. Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry.
Holm NB; Pedersen AJ; Dalsgaard PW; Linnet K
Drug Test Anal; 2015 Mar; 7(3):199-206. PubMed ID: 24802286
[TBL] [Abstract][Full Text] [Related]
4. Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?
Ford LT; Berg JD
Ann Clin Biochem; 2017 Mar; 54(2):219-229. PubMed ID: 27166311
[TBL] [Abstract][Full Text] [Related]
5. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
Borg D; Tverdovsky A; Stripp R
J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
[TBL] [Abstract][Full Text] [Related]
6. Isomeric discrimination of synthetic cannabinoids by GC-EI-MS: 1-adamantyl and 2-adamantyl isomers of N-adamantyl carboxamides.
Asada A; Doi T; Tagami T; Takeda A; Sawabe Y
Drug Test Anal; 2017 Mar; 9(3):378-388. PubMed ID: 27770510
[TBL] [Abstract][Full Text] [Related]
7. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
8. Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H-indazole analogue, AMPPPCA, and 5F-AMPPPCA.
Jia W; Meng X; Qian Z; Hua Z; Li T; Liu C
Drug Test Anal; 2017 Feb; 9(2):248-255. PubMed ID: 26968728
[TBL] [Abstract][Full Text] [Related]
9. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
Liu C; Jia W; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
[TBL] [Abstract][Full Text] [Related]
10. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
Sobolevsky T; Prasolov I; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760
[TBL] [Abstract][Full Text] [Related]
11. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
Hutter M; Broecker S; Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
[TBL] [Abstract][Full Text] [Related]
12. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine.
Adamowicz P; Zuba D; Sekuła K
Forensic Sci Int; 2013 Dec; 233(1-3):320-7. PubMed ID: 24314536
[TBL] [Abstract][Full Text] [Related]
13. Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
Berg T; Kaur L; Risnes A; Havig SM; Karinen R
Drug Test Anal; 2016 Jul; 8(7):708-22. PubMed ID: 26304456
[TBL] [Abstract][Full Text] [Related]
14. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
[TBL] [Abstract][Full Text] [Related]
15. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
[TBL] [Abstract][Full Text] [Related]
16. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.
Yanes EG; Lovett DP
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():42-50. PubMed ID: 23153643
[TBL] [Abstract][Full Text] [Related]
17. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
Scheidweiler KB; Jarvis MJ; Huestis MA
Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
Yeter O; Ozturk YE
Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
[TBL] [Abstract][Full Text] [Related]
20. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
